These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 15559524

  • 1. [Therapy of heart failure after myocardial infarction. With eplerenone a new course].
    MMW Fortschr Med; 2004 Oct 21; 146(43):58-9. PubMed ID: 15559524
    [No Abstract] [Full Text] [Related]

  • 2. [Selective aldosterone blocking in heart failure. Eplerenone reduces the risk after infarction].
    MMW Fortschr Med; 2003 Oct 30; 145(44):42-3. PubMed ID: 14655506
    [No Abstract] [Full Text] [Related]

  • 3. [More benefit in hypertension and high-grade reduction of the pump performance. Earlier beginning of therapy maximizes the benefit].
    MMW Fortschr Med; 2004 Oct 21; 146(43):59. PubMed ID: 15559525
    [No Abstract] [Full Text] [Related]

  • 4. Cost effectiveness of eplerenone in patients with heart failure after acute myocardial infarction who were taking both ACE inhibitors and beta-blockers: subanalysis of the EPHESUS.
    Zhang Z, Mahoney EM, Kolm P, Spertus J, Caro J, Willke R, Weintraub WS.
    Am J Cardiovasc Drugs; 2010 Oct 21; 10(1):55-63. PubMed ID: 20104935
    [Abstract] [Full Text] [Related]

  • 5. [Heart failure after acute myocardial infarct. Early aldosterone blockade increases survival rate].
    MMW Fortschr Med; 2005 Jul 07; 147(27-28):44. PubMed ID: 16041942
    [No Abstract] [Full Text] [Related]

  • 6. Aldosterone antagonism in heart failure.
    Richards AM, Nicholls MG.
    Lancet; 1999 Sep 04; 354(9181):789-90. PubMed ID: 10485716
    [No Abstract] [Full Text] [Related]

  • 7. [Aldosterone and its antagonists in heart failure].
    Lopes ME, Le Corvoisier P, Tabet JY, Su JB, Badoual T, Cachin JC, Merlet P, Castaigne A, Hittinger L.
    Presse Med; 2003 Jan 18; 32(2):79-87. PubMed ID: 12653034
    [Abstract] [Full Text] [Related]

  • 8. More hope for heart failure. Findings suggest expanded use of aldosterone-blockers.
    Aaronson K.
    Health News; 2003 May 18; 9(5):4. PubMed ID: 12739453
    [No Abstract] [Full Text] [Related]

  • 9. [Combination drug therapy after myocardial infarction. Early aldosterone blocking protects risk patients].
    MMW Fortschr Med; 2006 Jun 15; 148(24):48-9. PubMed ID: 16850812
    [No Abstract] [Full Text] [Related]

  • 10. [Aldosterone receptor blockade after acute myocardial infarction with heart failure].
    Bauersachs J, Ertl G.
    Med Klin (Munich); 2006 Jun 15; 101(6):458-66. PubMed ID: 16767569
    [Abstract] [Full Text] [Related]

  • 11. [Aldosterone blocker in heart failure: life prolonging even in mild symptoms].
    MMW Fortschr Med; 2010 Dec 02; 152(48):12-3. PubMed ID: 21226226
    [No Abstract] [Full Text] [Related]

  • 12. [Cardioverter-defibrillator (ICD) and resynchronization in every patient with cardiac failure].
    Mundhenke M.
    Dtsch Med Wochenschr; 2006 Oct 13; 131(41):2297-8; author reply 2298. PubMed ID: 17036279
    [No Abstract] [Full Text] [Related]

  • 13. Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study.
    Krum H, Shi H, Pitt B, McMurray J, Swedberg K, van Veldhuisen DJ, Vincent J, Pocock S, Zannad F, EMPHASIS-HF Study Group.
    Circ Heart Fail; 2013 Jul 13; 6(4):711-8. PubMed ID: 23625945
    [Abstract] [Full Text] [Related]

  • 14. The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study.
    Pitt B, Williams G, Remme W, Martinez F, Lopez-Sendon J, Zannad F, Neaton J, Roniker B, Hurley S, Burns D, Bittman R, Kleiman J.
    Cardiovasc Drugs Ther; 2001 Jan 13; 15(1):79-87. PubMed ID: 11504167
    [No Abstract] [Full Text] [Related]

  • 15. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ, Pfeffer MA, Swedberg K, Dzau VJ.
    Circulation; 2004 Nov 16; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract] [Full Text] [Related]

  • 16. [Results of the RALES trial: good news for patients with heart failure and ... for health administrations].
    Azpitarte Almagro J.
    Med Clin (Barc); 2000 Apr 15; 114(14):545-50. PubMed ID: 10846668
    [No Abstract] [Full Text] [Related]

  • 17. [Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study].
    Watanabe J.
    Nihon Rinsho; 2007 Apr 28; 65 Suppl 4():543-6. PubMed ID: 17508588
    [No Abstract] [Full Text] [Related]

  • 18. Aldosterone antagonists: a new treatment option for patients with post-myocardial infarction heart failure.
    Ajani AE, Marwick TH, Krum H.
    Cardiovasc Revasc Med; 2006 Apr 28; 7(4):234-6. PubMed ID: 17174870
    [Abstract] [Full Text] [Related]

  • 19. [Drug treatment of chronic heart failure].
    Böhm M, Werner N, Kindermann M.
    Clin Res Cardiol; 2006 Apr 28; 95 Suppl 4():36-54; quiz 55-6. PubMed ID: 16598606
    [Abstract] [Full Text] [Related]

  • 20. Aldosterone blockade after myocardial infarction.
    Hackam DG.
    CMAJ; 2003 Sep 02; 169(5):444. PubMed ID: 12952808
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.